Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 31, 2007

Medarex and Mitsubishi Join Forces to Target Autoimmune Diseases

  • Medarex is partnering with Mitsubishi Pharma to generate and evaluate fully human mAbs against a Mitsubishi target for the treatment of autoimmune diseases.

    The companies will use Medarex' UltiMAb Human Antibody Development System® to generate antibodies. The companies will share research responsibilities for any antibodies found through the collaboration.

  • You’re all set! Thank you for subscribing to GEN Highlights.